Ebola has not been eradicated, however. This deadly virus, which causes severe hemorrhagic ... of the detailed nucleocapsid using single-particle cryo-electron microscopy, visualizing molecular ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

NV-387 mimics HSPG, presents itself as a decoy to the virus, and is capable of destroying the virus particle thereby stalling ... Dengue fever, and Ebola virus, among others.

Promega technology used in the development of vaccines for infectious viral diseases will support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations' (CEPI's ...

With a viral vector, there is essentially a viral particle, which is programmed not ... killing them before the virus spreads. “With the initial single dose of Convidecia, we have over 90% ...

After challenge with live RSV A2 virus in cotton rats, the protection and safety of ... mRNA vaccines targeting the SARS-CoV-2, Ebola, Zika, and influenza viruses, as well as cancer, have been ...

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola ...

For the first time in Finland, researchers at the Nanoscience Center in University of Jyväskylä, Finland, have isolated a ...